GF/B09/DP18
Approved by the Board on: 19 November 2004
Quality Assurance of Single- and Limited-Source Pharmaceutical Products
The Board replaces the phrase "Option (c) is applicable only until December 31, 2004" in the Board decision on quality assurance (compliance with quality standards) from the Third Board Meeting (GF/B4/2, p. 23) with "Option (c) is applicable only until December 31, 2005
The Board invites the World Health Organization to work with the Secretariat to assess the impact of the expiry of the transition period established in Option (c) and to develop options on the quality assurance of single- and limited-source products, and to report back to the PMPC in time for the development of recommendations for the Tenth Board Meeting.
Budgetary Implications
The additional cost of implementing this decision is estimated as US$60,000.